CRBU CARIBOU BIOSCIENCES INC
2026Q1 · CUSIP 142038108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
135
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
68
Δ whales
+8
Inst. holding value
$71M
New positions
28
Closed positions
17
Price momentum (1Q)
—
Put / Call
2/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2022Q4 | Top 19% | -36.0% | -8.6% |
| 2022Q2 | Top 7% | -4.5% | -37.1% |
| 2022Q1 | Top 19% | +7.7% | +4.4% |
Options Sentiment
Put holders
2
QoQ: 0
Call holders
3
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.42
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+13.0%
Net margin
—
ROE
-130.6%
Debt ratio
31.5%
FCF (TTM)
-$102M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.